Close Menu

NEW YORK (GenomeWeb) – LGC said today that it has acquired BioAutomation, which manufactures the MerMade line of oligonucleotide synthesis instruments.

Terms of the deal were not disclosed.

BioAutomatic was founded in 1999 and employs 17 people at its facility in Irving, Texas. Its MerMade products include eight instruments that can synthesize four to 192 oligos simultaneously at scale ranges from 50 nmol to 200 umol, according to LGC. It also distributes consumables used during the synthesis process.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.